Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-020014-28Phase 4Completed
Phase 4 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Saliva methylphenidate concentrations and Plasma methylphenidate concentrations. Started Apr 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-020014-28.